Page 1267 - Clinical Small Animal Internal Medicine
P. 1267

1205


  VetBooks.ir






               130


               Biology of Cancer and Cancer Genetics
               Mary‐Keara Boss, DVM, PhD, DACVR (Radiation Oncology)

               Colorado State University, Fort Collins, CO, USA



               Veterinary patients develop cancer in all tissues of the   This chapter on the biology of cancer and cancer
               body, and these neoplasms are characterized according     genetics is organized in accordance with the hallmarks
               to their cell type of origin: carcinoma  –  epithelial;   of cancer. Each section will review the cancer biology
                 sarcoma – mesenchymal; round cell tumor – typically of   and genetics underlying the particular neoplastic char-
               the hematopoietic system. Cells can transition from a   acteristic being discussed, followed by examples of the
               normal phenotype to malignancy through acquisition of     relevance of the abnormality in clinical small animal
               mutations of certain types of genes. Oncogenes are   oncology today. Topics were assigned to a particular
               defined as those which code for proteins that allow     hallmark, and although it is recognized that overlaps in
                 dysregulated tumor cell growth and proliferation, while   content exist, this organization allowed a concise but in
               tumor suppressor genes, which normally restrain cell   no way comprehensive account of how the biology and
               growth, allow cancer cells to grow and divide indefinitely   genetics of veterinary cancer may be conceptualized.
               when absent or inactivated by mutation. The abnormal   Further, the hallmarks are organized in an order that
               characteristics and behaviors of cancerous cells and   allows the topics to progress from cellular to microen-
                 tissues share commonalities, such that the neoplastic   vironmental effects. Clinical aspects of each category
               transformations  and  progression  pathways  have  been   will be highlighted; however, for more detailed discus-
               defined according to various hallmarks of cancer.  sions, see chapters devoted to specific tumor types.
                 In their 2011 review, Hanahan and Weinberg revised
               and expanded upon their initially described hallmarks.     Enabling Replicative Immortality
               The original six hallmarks are:

               ●   enabling replicative immortality               Cancer cells require the ability to replicate unlimitedly,
               ●   evading growth suppressors                     uninhibited by normal space restrictions, to form a
               ●   resisting cell death                             macroscopic tumor. Normal cells will progress through
               ●   sustaining proliferative signaling             a  tightly  regulated,  limited  number  of  cell  divisions;
               ●   inducing angiogenesis                            thereupon, they face either senescence, which is an
               ●   activating invasion and metastasis.              irreversible, nonproliferative, viable state, or crisis (cell
                                                                  death). Cancer cells do not respect the bounds of senes-
               As new developments in cancer biology were discovered,   cence or crisis, and attain a state of immortality.
               emerging hallmarks that involve the complex tumor    The classic in vitro demonstration of unlimited replica-
               microenvironment were added:
                                                                  tion is the ability to continuously grow and passage tumor
               ●   avoiding immune destruction                    cells in cell culture in the laboratory setting. The develop-
               ●   deregulating cellular energetics and enabling charac-  ment and maintenance of cancer cell lines in vitro have
                 teristics crucial to the acquisition of the original   allowed for molecular characterization of specific tumor
                   hallmark capabilities                          types and evaluation of therapeutic responses through
               ●   genome instability and mutation                experimental manipulations at the cellular level. Recent
               ●   tumor promoting inflammation.                  research utilizing veterinary cancer cell lines includes




               Clinical Small Animal Internal Medicine Volume II, First Edition. Edited by David S. Bruyette.
               © 2020 John Wiley & Sons, Inc. Published 2020 by John Wiley & Sons, Inc.
               Companion website: www.wiley.com/go/bruyette/clinical
   1262   1263   1264   1265   1266   1267   1268   1269   1270   1271   1272